Nanobiotix (NBTX) Debt to Equity (2020 - 2025)
Nanobiotix has reported Debt to Equity over the past 6 years, most recently at -$1.13 for Q4 2025.
- For Q4 2025, Debt to Equity fell 45.64% year-over-year to -$1.13; the TTM value through Dec 2025 reached -$1.13, down 45.64%, while the annual FY2025 figure was -$1.13, 45.64% down from the prior year.
- Debt to Equity for Q4 2025 was -$1.13 at Nanobiotix, down from -$0.74 in the prior quarter.
- Over five years, Debt to Equity peaked at $25.17 in Q2 2022 and troughed at -$27.44 in Q4 2023.
- A 5-year average of -$0.64 and a median of -$0.89 in 2023 define the central range for Debt to Equity.
- Biggest five-year swings in Debt to Equity: skyrocketed 1956.17% in 2022 and later tumbled 2214.45% in 2023.
- Year by year, Debt to Equity stood at $1.72 in 2021, then crashed by 169.01% to -$1.19 in 2022, then tumbled by 2214.45% to -$27.44 in 2023, then surged by 97.18% to -$0.77 in 2024, then plummeted by 45.64% to -$1.13 in 2025.
- Business Quant data shows Debt to Equity for NBTX at -$1.13 in Q4 2025, -$0.74 in Q2 2025, and -$0.77 in Q4 2024.